Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Brintellix® (vortioxetine) for the treatment of major depressive disorder in adults is now available in U.S. pharmacies

13:53 EST 22 Jan 2014 | Takeda

Valby, Denmark, 21 January 2014 and Osaka, Japan, 22 January 2014 - H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) jointly announced today that Brintellix (vortioxetine), for the treatment of major depressive disor...

Original Article: Brintellix® (vortioxetine) for the treatment of major depressive disorder in adults is now available in U.S. pharmacies

NEXT ARTICLE

More From BioPortfolio on "Brintellix® (vortioxetine) for the treatment of major depressive disorder in adults is now available in U.S. pharmacies"

Search BioPortfolio: